Ransom Advisory, LTD Exact Sciences Corp Transaction History
Ransom Advisory, LTD
- $202 Billion
- Q1 2025
A detailed history of Ransom Advisory, LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Ransom Advisory, LTD holds 200 shares of EXAS stock, worth $11,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$11,388% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1.02 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$1 Billion0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$712 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$687 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$377 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.1B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...